Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Machine learning can help find new ways to treat alopecia areata.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Assessing blood flow can improve skin graft success.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Abatacept may help some people with alopecia areata regrow hair.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

The new bioreactor improves skin grafts by evenly stretching cells and monitoring conditions for better growth.

The new artificial derma is better for skin regeneration and biocompatibility.

A new method using hair pores can help align skin grafts better, improving results.

Micro-grafts improved hair growth in patients with hair loss.

Micrografts improve hair density and thickness without side effects.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A manual blood cell counter was effectively used to count hair follicles during surgery, being user-friendly and cost-effective but limited by a three-digit display.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

Micrografts are useful for healing wounds, regenerating bone and periodontal tissues, and improving hair transplantation outcomes.

LC-OCT is a useful noninvasive tool for diagnosing and monitoring alopecia areata.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Follicular microautotransplantation effectively improves scalp scars and enhances quality of life.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

Mice with autoimmune hair loss showed signs of heart problems.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.